Korean Oligo Manufacturer Bioneer Opens US Subsidiary

Oct 11, 2006

NEW YORK (GenomeWeb News) – Korean oligo manufacturer Bioneer has opened a US subsidiary in Alameda, Calif. today, the Korean biotech company said today.

Bioneer selected the site for its manufacturing facility and distribution center to be near San Francisco’s biotech hub and “for environmental conditions ideally suited” to synthetic oligonucleotide production.

The 22,000-square-foot facility will have the capacity to manufacture 6,000 oligos per day. The fir said capacity will rise with increased demand.

Since its IPO in December 2005, Bioneer has expanded into North America and Europe. The company delivers oligos in combination with its AccuPower technology for PCR.

Filed under

Microarrays & Multiplexing

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.